Genentech

MILESTONES San Francisco–based Genentech received FDA approval this spring for an MS drug called Ocrevus, the first medication for the most severe form of the disease. The drug went on the market in April. CHALLENGES Though the FDA approved Genentech’s bladder cancer treatment last year, the drug recently failed a late-stage trial, which could cause the FDA to overturn its ruling. BUZZ